Rosa Conde Vicente-rekin lankidetzan egindako argitalpenak (7)

2012

  1. Basal Glucagonlike peptide 1 levels and metabolic syndrome in obese patients

    Journal of Investigative Medicine, Vol. 60, Núm. 6, pp. 874-877

  2. Interaction of -55CT polymorphism of UCP3 gene with Trp64Arg polymorphism of beta3adrenoreceptor gene on insulin resistance in obese patients

    European Review for Medical and Pharmacological Sciences, Vol. 16, Núm. 5, pp. 610-616

  3. Relationship among metabolic syndrome, C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance

    Journal of Diabetes and its Complications, Vol. 26, Núm. 4, pp. 328-332

2011

  1. Circulating adipocytokines in morbid obese patients, relation with cardiovascular risk factors and anthropometric parameters

    Nutricion Hospitalaria, Vol. 26, Núm. 1, pp. 91-96

  2. Lys656Asn polymorphism of leptin receptor gene and metabolic syndrome in obese patients

    European Review for Medical and Pharmacological Sciences, Vol. 15, Núm. 5, pp. 463-468

2010

  1. Effects of olmesartan vs irbesartan on metabolic parameters and visfatin in hypertensive obese women

    European Review for Medical and Pharmacological Sciences, Vol. 14, Núm. 9, pp. 759-763

  2. Lack of effect of a moderate hypocaloric diet on visfatin levels in morbid obese patients: Relationship with insulin resistance

    European Review for Medical and Pharmacological Sciences, Vol. 14, Núm. 12, pp. 1031-1036